These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37377284)

  • 1. Correlation of systemic inflammation biomarkers and disease severity in pregnant women with COVID-19.
    Gündüz Ö; Seven B; Ozgu-Erdınc AS; Ayhan SG; Sahin D; Tekin OM; Keskin HL
    Rev Assoc Med Bras (1992); 2023; 69(6):e20221614. PubMed ID: 37377284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?
    Vaira LA; De Vito A; Deiana G; Pes C; Giovanditto F; Fiore V; Lechien JR; Saussez S; Policicchio D; Boccaletti R; Madeddu G; Babudieri S; Pazzola A; Bandiera F; Fois AG; Piana AF; Hopkins C; De Riu G
    J Laryngol Otol; 2021 Aug; 135(8):723-728. PubMed ID: 34184623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
    Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
    Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of laboratory parameters in predicting severity of COVID-19 disease in pregnant patients.
    Sahin O; Aktoz F; Bagci H; Vurgun E
    J Obstet Gynaecol; 2022 Aug; 42(6):1917-1921. PubMed ID: 35603633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory analysis of symptomatic and asymptomatic pregnant patients with SARS-CoV-2 infection.
    Fisher SA; Goldstein JA; Mithal LB; Isaia AL; Shanes ED; Otero S; Miller ES
    Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100458. PubMed ID: 34403821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity and coagulation and fibrinolytic processes may reduce the risk of severe illness in pregnant women with coronavirus disease 2019.
    Zhong Y; Cao Y; Zhong X; Peng Z; Jiang S; Tang T; Chen H; Li X; Xia Y; Cheng Y; Zhao X
    Am J Obstet Gynecol; 2021 Apr; 224(4):393.e1-393.e25. PubMed ID: 33098813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study.
    Maamar M; Artime A; Pariente E; Fierro P; Ruiz Y; Gutiérrez S; Tobalina M; Díaz-Salazar S; Ramos C; Olmos JM; Hernández JL
    Curr Med Res Opin; 2022 Jun; 38(6):901-909. PubMed ID: 35166141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and laboratory results of pregnant women with COVID-19 in Wuhan, China.
    Wang Z; Wang Z; Xiong G
    Int J Gynaecol Obstet; 2020 Sep; 150(3):312-317. PubMed ID: 32510581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19.
    Xue G; Gan X; Wu Z; Xie D; Xiong Y; Hua L; Zhou B; Zhou N; Xiang J; Li J
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107065. PubMed ID: 33045571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of D-Dimer, C-Reactive Protein, and Ferritin with COVID-19 Severity in Pregnant Women: Important Findings of a Cross-Sectional Study in Northern Brazil.
    Paixão JTR; Santos CJSE; França APFM; Lima SS; Laurentino RV; Fonseca RRS; Vallinoto ACR; Oliveira-Filho AB; Machado LFA
    Int J Environ Res Public Health; 2023 Jul; 20(14):. PubMed ID: 37510647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of immune-inflammatory markers in predicting clinical outcome of COVID-19 patients.
    Singh A; Bhadani PP; Surabhi ; Sinha R; Bharti S; Kumar T; Nigam JS
    Indian J Pathol Microbiol; 2023; 66(1):111-117. PubMed ID: 36656221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in determinants of COVID-19 severe outcomes - findings from the National COVID Cohort Collaborative (N3C).
    Yoshida Y; Chu S; Fox S; Zu Y; Lovre D; Denson JL; Miele L; Mauvais-Jarvis F
    BMC Infect Dis; 2022 Oct; 22(1):784. PubMed ID: 36224551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it possible to identify COVID-19 infection-related biomarkers during pregnancy?: A prospective study in Turkish population.
    Özer Aslan İ; Doğan K; Kural A; Baghaki S; Helvaci N; Ekin M; Yaşar L
    Medicine (Baltimore); 2024 May; 103(19):e38062. PubMed ID: 38728492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and laboratory characteristics of COVID-19 in pregnant women.
    Pryshliak OY; Marynchak OV; Kondryn OY; Hryzhak IH; Henyk NI; Makarchuk OM; Golovchak IS; Boichuk OP; Protsyk AL; Prokofiev MV
    J Med Life; 2023 May; 16(5):766-772. PubMed ID: 37520486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Sequentially Monitored Laboratory Values and Inflammatory Biomarkers in Assessing the Severity of COVID-19.
    Baran B; Yetkin NA; Tutar N; Türe Z; Oymak FS; Gülmez İ
    Cureus; 2024 Jan; 16(1):e51458. PubMed ID: 38298278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
    Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y
    Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the relationships between procalcitonin and neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with pneumonia.
    Çil E; Karadeniz G; Yenigün S; Çoraplı G
    Eur Rev Med Pharmacol Sci; 2022 May; 26(9):3200-3205. PubMed ID: 35587071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index in patients with COVID-19-associated pneumonia.
    Carpio-Orantes LD; García-Méndez S; Hernández-Hernández SN
    Gac Med Mex; 2020; 156(6):527-531. PubMed ID: 33877106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT Quantitative Analysis and Its Relationship with Clinical Features for Assessing the Severity of Patients with COVID-19.
    Sun D; Li X; Guo D; Wu L; Chen T; Fang Z; Chen L; Zeng W; Yang R
    Korean J Radiol; 2020 Jul; 21(7):859-868. PubMed ID: 32524786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of hematological parameters and inflammatory markers in children with COVID-19.
    Alkan G; Sert A; Emiroglu M; Tuter Oz SK; Vatansev H
    Ir J Med Sci; 2022 Aug; 191(4):1725-1733. PubMed ID: 34529237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.